<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04265157</url>
  </required_header>
  <id_info>
    <org_study_id>LDLT</org_study_id>
    <nct_id>NCT04265157</nct_id>
  </id_info>
  <brief_title>Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant</brief_title>
  <official_title>Hepato-duodenal Ligament Occlusion Versus Classic Technique During Recipient Hepatectomy in Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Liver transplantation was historically associated with massive blood loss. Many factors have
      contributed to the decline in bleeding and transfusion in the past two decades including
      refinement of surgical techniques, anesthetics management and the use of point of care guided
      goal-directed hemostatic therapies. Increasing awareness of the adverse associations of
      allogenic transfusion has driven the quest for transfusion-free transplantation.
      Pre-operative management of preoperative anemia and targeted correction of coagulopathy is
      done to decrease blood transfusion. Liver transplantation is associated with the potential
      for massive operative blood loss, which has been recognized as one of the main causes of
      morbidity and mortality after liver transplantation. Therefore, a fine surgical procedure to
      reduce intraoperative hemorrhage is necessary for favorable outcomes of liver
      transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The amount of intraoperative blood loss measure by Cubic Cm</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Liver Transplant</condition>
  <arm_group>
    <arm_group_label>Early occlusion of hepatoduodenal ligament</arm_group_label>
    <description>Early occlusion of hepatoduodenal ligament during mobilization of the liver of the recipient by using portal vein clamp or occlusive temporary bands.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>classical occlusion of hepatoduodenal ligament</arm_group_label>
    <description>classical occlusion of hepatoduodenal ligament after mobilization of the liver of the recipient immediately before explantation by suing of portal vein clamp</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical technique surgical occlusion</intervention_name>
    <description>Occlusion of hepatoduodenal ligament by clamp or occlusive bands</description>
    <arm_group_label>Early occlusion of hepatoduodenal ligament</arm_group_label>
    <arm_group_label>classical occlusion of hepatoduodenal ligament</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We will included in the study all patients accepted for Living Donor LiverTransplantation
        (LDLT) according to hospital protocol
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients undergoing Living Donor Liver Transplantation accepted according to
             hospital protocol

          -  All patients with liver Cirrhosis who have Porto systemic collaterals based on ct
             angiography

        Exclusion Criteria:

          -  Acute fulminant liver failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ahmed Elkoussy, Master</last_name>
    <phone>+20010!17739</phone>
    <email>ahmdkoussy91@gmail.com</email>
  </overall_contact>
  <reference>
    <citation>Donohue CI, Mallett SV. Reducing transfusion requirements in liver transplantation. World J Transplant. 2015 Dec 24;5(4):165-82. doi: 10.5500/wjt.v5.i4.165. Review.</citation>
    <PMID>26722645</PMID>
  </reference>
  <reference>
    <citation>Park YK, Kim BW, Wang HJ, Xu W. Usefulness of the Pinch-Burn-Cut (PBC) technique for recipient hepatectomy in liver transplantation. Korean J Hepatobiliary Pancreat Surg. 2012 Feb;16(1):13-6. doi: 10.14701/kjhbps.2012.16.1.13. Epub 2012 Feb 29.</citation>
    <PMID>26388900</PMID>
  </reference>
  <reference>
    <citation>Houben P, Khajeh E, Hinz U, Knebel P, Diener MK, Mehrabi A. SEALIVE: the use of technical vessel-sealing devices for recipient hepatectomy in liver transplantation: study protocol for a randomized controlled trial. Trials. 2018 Jul 16;19(1):380. doi: 10.1186/s13063-018-2778-1.</citation>
    <PMID>30012178</PMID>
  </reference>
  <reference>
    <citation>Choi JU, Hwang S, Ahn CS, Moon DB, Ha TY, Kim KH, Song GW, Jung DH, Park GC, Lee SG. Prolonged occlusion of the hepatoduodenal ligament to reduce risk of bleeding and tumor spread during recipient hepatectomy for living donor liver transplantation. Ann Hepatobiliary Pancreat Surg. 2019 Feb;23(1):61-64. doi: 10.14701/ahbps.2019.23.1.61. Epub 2019 Feb 28.</citation>
    <PMID>30863809</PMID>
  </reference>
  <reference>
    <citation>Lee KF, Wong J, Cheung SYS, Chong CCN, Hui JWY, Leung VYF, Yu SCH, Lai PBS. Does Intermittent Pringle Maneuver Increase Postoperative Complications After Hepatectomy for Hepatocellular Carcinoma? A Randomized Controlled Trial. World J Surg. 2018 Oct;42(10):3302-3311. doi: 10.1007/s00268-018-4637-3.</citation>
    <PMID>29696328</PMID>
  </reference>
  <reference>
    <citation>Cleland S, Corredor C, Ye JJ, Srinivas C, McCluskey SA. Massive haemorrhage in liver transplantation: Consequences, prediction and management. World J Transplant. 2016 Jun 24;6(2):291-305. doi: 10.5500/wjt.v6.i2.291. Review.</citation>
    <PMID>27358774</PMID>
  </reference>
  <reference>
    <citation>Yoon JU, Byeon GJ, Park JY, Yoon SH, Ryu JH, Ri HS. Bloodless living donor liver transplantation: Risk factors, outcomes, and diagnostic predictors. Medicine (Baltimore). 2018 Dec;97(50):e13581. doi: 10.1097/MD.0000000000013581.</citation>
    <PMID>30558025</PMID>
  </reference>
  <reference>
    <citation>Kornberg A, Witt U, Kornberg J, Ceyhan GO, Mueller K, Friess H, Thrum K. Prognostic Impact of Intraoperative Blood Loss in Liver Transplant Patients with Advanced Hepatocellular Carcinoma. Anticancer Res. 2016 Oct;36(10):5355-5364. Epub 2016 Oct 10.</citation>
    <PMID>27798899</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 29, 2020</study_first_submitted>
  <study_first_submitted_qc>February 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2020</study_first_posted>
  <last_update_submitted>February 9, 2020</last_update_submitted>
  <last_update_submitted_qc>February 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed mahmoud mohammed elkoussy</investigator_full_name>
    <investigator_title>Assisstant lecturer</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

